WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013116291) IMIDAZO [4, 5 - B] PYRIDINE DERIVATIVES AS ALK AND JAK MODULATORS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2013/116291 International Application No.: PCT/US2013/023778
Publication Date: 08.08.2013 International Filing Date: 30.01.2013
IPC:
C07D 471/04 (2006.01) ,C07D 491/107 (2006.01) ,A61K 31/437 (2006.01) ,A61K 31/5377 (2006.01) ,A61K 31/496 (2006.01) ,A61K 31/4545 (2006.01) ,A61K 31/444 (2006.01) ,A61K 31/506 (2006.01) ,A61P 35/00 (2006.01)
Applicants: CEPHALON, INC.[US/US]; 41 Moores Road P.O. Box 4011 Frazer, Pennsylvania 19355, US
Inventors: BRESLIN, Henry J.; US
CURRY, Matthew A.; US
GINGRICH, Diane E.; US
LEARN, Keith S.; US
OTT, Gregory R.; US
WAGNER, Jason C.; US
Agent: NARDONE, Rona A.; Cephalon, Inc. 41 Moores Road Frazer, Pennsylvania 19355, US
Priority Data:
61/592,07430.01.2012US
Title (EN) IMIDAZO [4, 5 - B] PYRIDINE DERIVATIVES AS ALK AND JAK MODULATORS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS
(FR) DÉRIVÉS IMIDAZO [4,5-B] PYRIDINE COMME MODULATEURS D'ALK ET DE JAK POUR LE TRAITEMENT DE TROUBLES PROLIFÉRATIFS
Abstract: front page image
(EN) This application relates to compounds of the Formula I as defined herein, and/or salts thereof. This application further relates to compositions and methods of using these compounds and/or salts thereof. The compounds of Formula I are useful as ALK and JAK modulators for the treatment of proliferative disorders.
(FR) La présente invention concerne des composés de formule I tels que définis ici et/ou leurs sels. La présente invention concerne des compositions et des procédés d'utilisation desdits composés et/ou de leurs sels. Les composés de formule I sont utiles comme modulateurs d'ALK et de JAK pour le traitement de troubles prolifératifs.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)